Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deals and Financings

Set Alert for Deals

Medtech Money Flow: M&A & VC Deals, Jan. 7-13, 2019

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, from Jan. 7-13, 2019.

M & A Financing Deals

Latest From Deals

Device Week, Jan. 18, 2019 - Key Topics At This Year's JP Morgan Healthcare Conference

On this week's podcast, Medtech Insight's Catherine Longworth chats with Marion Webb about some key takeaways from this year's JP Morgan Healthcare Conference. That includes a Q&A with Smith & Nephew's new CEO Namal Nawana on his growth strategy for the British medtech giant, new partnership announcements between medtech and tech companies, and trends in digital health.

Device Week Deals

Abbott Advances Transcath Mitral Valve Efforts With Cephea Acquisition

Abbott has exercised an option to buy Cephea Valve Technologies, developer of a minimally-invasive replacement heart valve, for an undisclosed sum.

Cardiovascular M & A

QUOTED. Jan. 11, 2019. Ben Newton.

GE Healthcare is collaborating with Vanderbilt University Medical Center to develop AI-powered diagnostic tools for cancer care. Ben Newton, GE Healthcare's chief digital officer, explained that GE hopes the partnership will help GE become a leader in precision medicine by developing algorithms and artificial intelligence systems that can predict adverse events in cancer patients.

Quoted Deals

Ascensia Inks Distribution Deal To Enter CGM Market

Ascensia Diabetes Care plans to start selling its first continuous glucose monitoring devices this year based on a distribution deal with Zhejiang POCTech Co. Ltd, announced Jan. 7 at the JP Morgan Healthcare Conference. The partnership will also include product development.

Deals Commercial

Nexstim Targets Canadian Market With New Distributor Agreement

Neuromodulation firm Nexstim will launch its SmartFocus TMS system for treating major depressive disorder (MDD) in Canada after signing an exclusive agreement with distributor Canada Health Solutions CHS.

Canada Deals

Medtech Money Flow: M&A & VC Deals, Dec. 31, 2018-Jan. 6, 2019

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, from Dec. 31, 2018, through Jan. 6, 2019.

Financing M & A

QUOTED. Jan. 7, 2019. Bonnie Anderson.

Diagnostics firm Veracyte signed a deal to combine clinical study cohorts with Johnson & Johnson to accelerate development of two nasal swab tests for early detection of lung cancer. See how CEO Bonnie Anderson describes the arrangement here.

Quoted Deals

Johnson & Johnson Joins Forces With Veracyte For Lung Cancer Diagnostics

Johnson & Johnson has entered a strategic collaboration with genomics diagnostics company Veracyte to develop and commercialize tests for detecting lung cancer.

Deals Cancer

Boston Scientific Makes A Move In Mitral Valve, Sealing $325M Deal With Millipede

Boston Scientific has acquired the remaining shares of privately held mitral-valve repair device company Millipede for $325m.

Cardiovascular M & A
See All